Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    ISSN: 1432-055X
    Keywords: Schlüsselwörter: Sevofluran – Isofluran – Aufwachzeit – Hämodynamik – Unerwünschte Wirkung ; Key words: Sevoflurane – Isoflurane – Emergence time – Haemodynamics – Adverse effect
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Abstract. Sevoflurane is a "new" volatile inhaled anaesthetic that is currently undergoing phase III clinical trial in Europe and the United States. Owing to the low blood solubility, rapid induction of anaesthesia and emergence from anaesthesia would be expected. In this study, we compared emergence times and haemodynamics in patients receiving either sevoflurane or isoflurane. Furthermore, all adverse effects were recorded and the relationship to the drug administered was rated. Methods. Fifty ASA physical status I and II patients were studied in an open, prospective, randomised clinical trial. Anaesthesia was induced with fentanyl, thiopentone, and vecuronium for facilitating endotracheal intubation and maintained with sevoflurane or isoflurane, 60% nitrous oxide (N2O) in oxygen (O2), and additional doses of fentanyl (1 – 2 µg/kg⋅h). The electrocardiogram, blood pressure (non-invasive), O2 saturation, temperature, and end-tidal concentrations of sevoflurane or isoflurane, N2O, and carbon dioxide were monitored continuously. At the end of surgery, administration of sevoflurane or isoflurane and N2O was discontinued without tapering and emergence times were recorded. All adverse events that occurred until the 3rd postoperative day were recorded and the relationship to the inhaled anaesthetic was rated as "none", "unlikely", "possible", "probable", or "highly probable". Results. With the exception of gender, the two patient groups were comparable (Tables 1 and 2). Due to the higher MAC value, mean end-tidal concentrations were higher for sevoflurane (0.82% vs. 0.59% for isoflurane). The duration of anaesthetic exposure was 1.3 MAC h (calculation with FIO2=1.0 MAC value) and 3.1 MAC h (calculation with FIO2=0.4 in N2O MAC value), respectively, for both inhaled anaesthetics. Pulmonary elimination was faster (Fig. 1) and emergence time shorter (7 min vs. 11.5 min, Table 3) with sevoflurane. There was no difference in the time courses of heart rate and mean arterial blood pressure (Figs. 2 and 3). No adverse effects with a "probable" or "highly probable" relationship to the inhaled anaesthetic were observed. Table 4 shows the adverse events with a possible relationship to the drug administered. Further evaluations of nausea, vomiting, and dizziness are shown in Table 5. Discussion. Emergence time after inhalation anaesthesia depends on pulmonary elimination and MACawake, that is, the end-tidal concentration that would allow opening of the eyes on verbal command. Pulmonary elimination depends on dose applied (MAC h), alveolar ventilation, and blood-gas solubility coefficient. Due to the lower blood-gas solubility coefficient (0.6 – 0.7 for sevoflurane vs. 1.3 – 1.4 for isoflurane) and in accordance with the investigations of Frink et al. [4] and Smith et al. [16], emergence time was significantly shorter with sevoflurane. Gender, the only difference between the two patient groups, does not influence pulmonary elimination and MACawake[8]. Supplementing inhalation anaesthesia with fentanyl, there was no difference in the time courses of heart rate and mean arterial blood pressure between sevoflurane and isoflurane. Adverse events with a possible relationship to the inhaled anaesthetic occurred in both groups.
    Notes: Zusammenfassung. Im Rahmen einer multizentrischen Studie, deren Ziel die Zulassung von Sevofluran in Europa und den USA ist, führten wir bei 50 Patienten eine offene, randomisierte, prospektive und vergleichende Untersuchung von Sevofluran und Isofluran hinsichtlich Aufwachzeiten, postoperativer Befindlichkeit, Hämodynamik und unerwünschter Wirkungen durch. Die Patientengruppen waren abgesehen von der Geschlechtsverteilung, die ohne Einfluß auf die Aufwachzeit ist, vergleichbar. Die applizierte Dosis betrug für beide Inhalationsanästhetika ca. 1.3 MAC-h (Berechnung für eine FIO2 von 1,0) bzw. 3,1 MAC-h (Berechnung für eine FIO2 von 0,4 und eine FIN2O von 0,6). Sevofluran wurde signifikant schneller pulmonal eliminiert und führte zu einem signifikant schnelleren Erwachen (7 min für Sevofluran vs. 11,5 min für Isofluran). Der postoperative Zustand der Patienten war in beiden Gruppen gleich gut. Herzfrequenz und Blutdruck zeigten im Verlauf keine Unterschiede zwischen Sevofluran und Isofluran. Unerwünschte Wirkungen, für die ein möglicher Kausalzusammenhang mit dem verwendeten Inhalationsanästhetikum herzustellen war, traten in beiden Gruppen auf (Tabelle 4).
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-055X
    Keywords: Schlüsselwörter Sevofluran ; Enfluran ; Fluorid ; Nierenfunktion ; Key words Sevoflurane ; Enflurane ; Fluoride ; Renal function
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Abstract Sevoflurane is a “new” volatile inhaled anaesthetic. Owing to its lower blood-gas solubility coefficient, emergence from anaesthesia is faster with sevoflurane than with isoflurane, enflurane, or halothane. Sevoflurane undergoes metabolic biodegradation, releasing inorganic fluoride ions that could produce nephrotoxicity. In this study, we compared serum inorganic fluoride concentrations (IFCs) in patients receiving either sevoflurane or enflurane. Furthermore, indices of renal function were evaluated until the 3rd postoperative day. Methods. Thirty patients with no history of renal or hepatic disease and with an anticipated duration of anaesthesia of at least 3 h were studied in an open, prospective, randomised clinical trial. Anaesthesia was induced with fentanyl, thiopentone, and vecuronium for facilitating endotracheal intubation. Anaesthesia was maintained with sevoflurane or enflurane, 60% nitrous oxide in oxygen, and additional doses of fentanyl. Blood samples for serum IFCs were obtained preoperatively and 2 and, if possible, 4 and 6 h after starting sevoflurane or enflurane, at the end of anaesthesia, and 1, 2, 4, 8, 12, 24, 48 and 72 h post-anaesthesia. Fluoride analysis was performed using an ion-selective electrode. Indices of renal function (serum sodium, osmolality, creatinine, urea, and uric acid, urine specific gravity, osmolality, and pH) were evaluated preoperatively, at the end of anaesthesia, and 24, 48, and 72 h post-anaesthesia. Results. The duration of anaesthetic exposure was approximately 1.65 MAC-h for both inhaled anaesthetics. Peak serum IFCs were higher with sevoflurane (34.5 μmol/l) than with enflurane (19.4 μmol/l). Fluoride levels decreased more rapidly with sevoflurane: 24 h post-anaesthesia there was no difference between sevoflurane and enflurane (Fig. 1). The area under the curve (AUC) was greater with sevoflurane (688 μmol/l·h) than with enflurane (591 μmol/l·h). For both groups correlation coefficients were higher for MAC-h and AUC than for MAC-h and peak serum IFC (Figs. 2 and 3). Indices of renal function did not change in either group. Discussion. In our study 1.69 MAC-h sevoflurane produced peak serum IFCs of 34.5 μmol/l. This is in accordance with the investigation of Frink et al. [4], who reported approximately 30 μmol/l after 1.4 MAC-h sevoflurane. Peak serum IFCs with sevoflurane were twice those with enflurane. Within the first 24 h post-anaesthesia, fluoride levels decreased more rapidly after sevoflurane. AUC may be more important than peak serum IFC in evaluating patients who are at risk for renal concentrating defects. In our study there was no evidence of renal dysfunction in either group.
    Notes: Zusammenfassung In einer offenen, randomisierten, prospektiven und vergleichenden Studie zwischen Sevofluran und Enfluran wurden bei 30 nierengesunden Patienten die Serumfluoridkonzentrationen und die exokrine Nierenfunktion bis zum 3. postoperativen Tag untersucht. Die applizierte Dosis betrug in beiden Gruppen ca. 1,65 MAC-Stunden. Die maximale Serumfluoridkonzentration war mit 34,5 μmol/l nach Sevofluran fast doppelt so hoch wie nach Enfluran (19,4 μmol/l). 24 h nach Anästhesieende war die Serumfluoridkonzentration in der Sevoflurangruppe auf ca. 25% des Maximalwerts abgefallen, in der Enflurangruppe auf ca. 40% des Maximalwerts. Ab diesem Zeitpunkt war kein Unterschied mehr zwischen den beiden Gruppen nachweisbar. Die Fluoridbelastung (Area under the curve, AUC) war nach Sevofluran (688 μmol/l·h) etwas größer als nach Enfluran (591 μmol/l·h). Die Korrelation von MAC-Stunden (applizierte Dosis) und AUC war in beiden Gruppen besser als die von MAC-Stunden und maximaler Serumfluoridkonzentration. Veränderungen von Laborvariablen (Natrium, Osmolalität, Kreatinin, Harnstoff und Harnsäure i.S., spez. Gewicht, Osmolalität und pH-Wert i.U.), die auf eine Nierenschädigung hinweisen würden, wurden nicht nachgewiesen.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...